Position in DGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$97,514,167
+$2,183,028 QoQ
Shares Held
460,081
-5.4% QoQ
Ownership
0.417%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#41
of 1,095 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CRAWFORD INVESTMENT COUNSEL INC holds $126,575,641 across 4 Diagnostics & Research names. DGX ranks #1 (77.0% of the industry book) .
All Filings in DGX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $97,514,167 | 460,081 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $95,331,139 | 486,433 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $86,157,471 | 496,499 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $94,228,850 | 494,432 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $87,113,185 | 484,959 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $84,461,256 | 499,180 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $77,535,854 | 513,959 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $78,798,224 | 507,557 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $68,624,377 | 501,347 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $55,555,055 | 417,362 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||